Tom Smart

Tom Smart is a seasoned biopharmaceutical executive currently serving as the CEO and Board Member of Actym Therapeutics, where they lead the development of innovative cancer therapies. Previously, Smart held leadership roles at multiple companies, including CEO and Board Chair positions at AnaptysBio and Gravitas Therapeutics, where they achieved significant financings and advancements in therapeutic products. Smart's extensive experience in corporate development includes pivotal roles at GenVec and XOMA, where they played key roles in IPO processes and major strategic partnerships. They hold an MBA in Finance and Marketing from The University of Chicago Booth School of Business and a BS in Biological Sciences from Cornell University. Additionally, Smart is a Board Member at RIGImmune, contributing to the advancement of RNA immunotherapies.